https://nerlynxhcp.com/component---src-pages-resources-tsx-6ea7ab4c856e02177680.js/

1"use strict";(self.webpackChunkspl004=self.webpackChunkspl004||[]).push([[414],{4556:function(A,i,t){t.r(i);var o=t(8479),e=t(812),a=t(7604),r=t(2445);const l={title:"Resources",order:7,screenShoot:!0,anchors:[{id:"resources-for-your-practice",label:"RESOURCES FOR YOUR PRACTICE",ariaLabel:"Resources for your practice"},{id:"puma-patient-lynx-patient-support",label:"PUMA PATIENT LYNX PATIENT SUPPORT",ariaLabel:"Puma patient Lynx patient support"},{id:"resources-for-your-patients",label:"RESOURCES FOR YOUR PATIENTS",ariaLabel:"Resources for your patients"}]};var n={name:"9clfcr",styles:"padding-top:60px;padding-bottom:60px;@media (min-width: 768px){display:block;padding-top:64px;padding-bottom:64px;}"},s={name:"jzta2d",styles:"margin-bottom:32px;margin-top:0px;@media (min-width: 768px){margin-bottom:48px;}"},p={name:"pkjpk5",styles:"margin-bottom:0px;margin-top:32px;@media (min-width: 768px){margin-top:48px;}"},g={name:"jzta2d",styles:"margin-bottom:32px;margin-top:0px;@media (min-width: 768px){margin-bottom:48px;}"},C={name:"1tlmwo2",styles:"margin-bottom:0px"},I={name:"jzta2d",styles:"margin-bottom:32px;margin-top:0px;@media (min-width: 768px){margin-bottom:48px;}"},m={name:"1tlmwo2",styles:"margin-bottom:0px"},d={name:"1eh3vn7",styles:"margin-bottom:1rem;margin-top:2rem;font-size:24px"},E={name:"jzta2d",styles:"margin-bottom:32px;margin-top:0px;@media (min-width: 768px){margin-bottom:48px;}"},S={name:"3b8ovx",styles:"margin-bottom:60px;margin-top:32px;font-size:14px;font-weight:700;@media (min-width: 768px){margin-bottom:64px;margin-top:48px;}"};i.default=A=>{var i;return(0,r.FD)(o.PE,{children:[(0,r.Y)(o.kW,{title:"Resources | NERLYNX® (neratinib) tablets",description:"Explore resources about NERLYNX® (neratinib) to utilize in your practice and with your HER2+ breast cancer patients. Please see important safety information and full Prescribing Information.",path:null===(i=A.location)||void 0===i?void 0:i.pathname}),(0,r.FD)(o.lq,{backgroundImage:a.A,headlinePadding:"right",characterWidth:70,backgroundStyle:{backgroundPosition:"63% 8%",backgroundSize:"auto 140%","@media (min-width: 768px)":{backgroundSize:"cover"}},titleStyle:{marginTop:"-1rem",marginBottom:"20px","@media (min-width: 768px)":{marginTop:"0px",marginBottom:"0px"}},halfHeight:!0,children:["Resources to utilize in your practice and with"," ",(0,r.Y)(o.le,{children:"your patients"})]}),(0,r.Y)(o.jD,{children:(0,r.Y)(o.hD,{data:l.anchors,horizontal:!0})}),(0,r.Y)("section",{id:"resources-for-your-practice",children:(0,r.FD)(o.Fe,{className:"resource-section",flavor:"light",css:n,children:[(0,r.Y)(o.H2,{cyan:!0,css:s,children:"Downloadable materials"}),(0,r.Y)(o.i,{customCss:[{display:"grid",gridTemplateColumns:"repeat(1, minmax(0, 1fr))",gap:"50px"}],className:"resource-grid full-row",children:(0,r.Y)(o.rK,{blue:!0,bgColor:"pastelYellow",barColor:"cyan",ctaText:"Enrollment Forms",description:"Enrollment to the Puma Patient Lynx Support Program. Both forms required for access to program.",customCss:{paddingTop:"1rem",paddingBottom:"1rem",textAlign:"center","--tw-text-opacity":"1",color:"rgba(var(--brand-gray), var(--tw-text-opacity, 1))","@media (min-width: 768px)":{paddingTop:"2rem",paddingBottom:"2rem"}},children:(0,r.FD)(o.i,{className:"resource-btns",customCss:{display:"flex",flexDirection:"column","@media (min-width: 768px)":{flexDirection:"row",flexWrap:"wrap",justifyContent:"center"}},children:[(0,r.FD)(o.i,{customCss:{display:"flex",flexDirection:"column","@media (min-width: 768px)":{flexDirection:"row",flexWrap:"wrap",justifyContent:"center"}},children:[(0,r.Y)(o.fd,{customCss:{display:"flex",justifyContent:"space-between",gap:"1rem"},to:"/pdf/PRC-US-NER-3305_HCP_EnrollmentForm.pdf",filename:"PRC-US-NER-3305_HCP_EnrollmentForm",children:"HCP: English"}),(0,r.Y)(o.fd,{customCss:{display:"flex",justifyContent:"space-between",gap:"1rem"},to:"/pdf/PRC-US-NER-3365_HCP_EnrollmentForm_Spanish.pdf",filename:"PRC-US-NER-3365_HCP_EnrollmentForm_Spanish",children:"HCP: Español"})]}),(0,r.FD)(o.i,{customCss:{display:"flex",flexDirection:"column","@media (min-width: 768px)":{flexDirection:"row",flexWrap:"wrap",justifyContent:"center"}},children:[(0,r.Y)(o.fd,{customCss:{display:"flex",justifyContent:"space-between",gap:"1rem"},to:"/pdf/PRC-US-NER-3338_Patient_EnrollmentForm.pdf",filename:"PRC-US-NER-3338_Patient_EnrollmentForm",children:"Patient: English"}),(0,r.Y)(o.fd,{customCss:{display:"flex",justifyContent:"space-between",gap:"1rem"},to:"/pdf/PRC-US—0033_Patient_EnrollmentForm_Spanish.pdf",filename:"PRC-US—0033_Patient_EnrollmentForm_Spanish",children:"Paciente: Esp

1añol"})]})]})})}),(0,r.FD)(o.i,{customCss:[{display:"flex",flexWrap:"wrap",justifyContent:"center",gap:"50px"}],children:[(0,r.Y)(o.rK,{blue:!0,bgColor:"pastelYellow",barColor:"cyan",customCss:{width:"100%",paddingTop:"1rem",paddingBottom:"1rem",textAlign:"center","--tw-text-opacity":"1",color:"rgba(var(--brand-gray), var(--tw-text-opacity, 1))","@media (min-width: 768px)":{width:"calc(50% - 25px)",paddingTop:"2rem",paddingBottom:"2rem"}},ctaText:"Prescribing Information",description:"Review the Full Prescribing Information for NERLYNX.",children:(0,r.Y)(o.fd,{customCss:{display:"flex",justifyContent:"space-between",gap:"1rem"},to:"/pdf/full-prescribing-information.pdf",filename:"NERLYNX Prescribing Information",children:"Download"})}),(0,r.Y)(o.rK,{blue:!0,bgColor:"pastelYellow",barColor:"cyan",customCss:{width:"100%",paddingTop:"1rem",paddingBottom:"1rem",textAlign:"center","--tw-text-opacity":"1",color:"rgba(var(--brand-gray), var(--tw-text-opacity, 1))","@media (min-width: 768px)":{width:"calc(50% - 25px)",paddingTop:"2rem",paddingBottom:"2rem"}},ctaText:"Dosing and Administration Guide",description:"Review information for your office staff about dosing, dose escalation, and treatment management.",children:(0,r.Y)(o.fd,{customCss:{display:"flex",justifyContent:"space-between",gap:"1rem"},to:"/pdf/PRC-US-NER-3235-dosing-and-administration-guide.pdf",filename:"NERLYNX Dosing & Admin Guide - PRC-US-NER-3235",children:"Download"})}),(0,r.Y)(o.rK,{blue:!0,bgColor:"pastelYellow",barColor:"cyan",customCss:{width:"100%",paddingTop:"1rem",paddingBottom:"1rem",textAlign:"center","--tw-text-opacity":"1",color:"rgba(var(--brand-gray), var(--tw-text-opacity, 1))","@media (min-width: 768px)":{width:"calc(50% - 25px)",paddingTop:"2rem",paddingBottom:"2rem"}},ctaText:"eBC HR- Data",description:"Review a brochure that includes data on patients with early-stage HER2+ HR- breast cancer.",children:(0,r.Y)(o.fd,{customCss:{display:"flex",justifyContent:"space-between",gap:"1rem"},to:"/pdf/PRC-US-NER-3306-ExteNET-Trial-eBC-HR-Efficacy-and-Safety-Outcomes.pdf",filename:"NERLYNX eBC HR- Data - PRC-US-NER-3306",children:"Download"})}),(0,r.Y)(o.rK,{blue:!0,bgColor:"pastelYellow",barColor:"cyan",customCss:{width:"100%",paddingTop:"1rem",paddingBottom:"1rem",textAlign:"center","--tw-text-opacity":"1",color:"rgba(var(--brand-gray), var(--tw-text-opacity, 1))","@media (min-width: 768px)":{width:"calc(50% - 25px)",paddingTop:"2rem",paddingBottom:"2rem"}},ctaText:"eBC Treatment Completion Data",description:(0,r.FD)(r.FK,{children:["Review a brochure that includes data on patients with early-stage HER2+ breast cancer who completed treatment with Nerlynx as planned in the ExteNET trial.",(0,r.Y)("sup",{children:"1,*"})]}),children:(0,r.Y)(o.fd,{customCss:{display:"flex",justifyContent:"space-between",gap:"1rem"},to:"/pdf/PRC-US-NER-2493-ExteNET-Trial-eBC-Treatment-Completion-Results.pdf",filename:"NERLYNX eBC Treatment Completion Data - PRC-US-NER-2493",children:"Download"})}),(0,r.Y)(o.rK,{blue:!0,bgColor:"pastelYellow",barColor:"cyan",customCss:{width:"100%",paddingTop:"1rem",paddingBottom:"1rem",textAlign:"center","--tw-text-opacity":"1",color:"rgba(var(--brand-gray), var(--tw-text-opacity, 1))","@media (min-width: 768px)":{width:"calc(50% - 25px)",paddingTop:"2rem",paddingBottom:"2rem"}},ctaText:"NALA Trial (mBC) Data",description:"Review a brochure describing the efficacy and safety data for NERLYNX + capecitabine in patients with metastatic HER2+ breast cancer.",children:(0,r.Y)(o.fd,{customCss:{display:"flex",justifyContent:"space-between",gap:"1rem"},to:"/pdf/PRC-US-NER-2564-NALA-Trial-mBC-Brochure.pdf",filename:"NERLYNX NALA Trial (mBC) Data - PRC-US-NER-2564",children:"Download"})})]}),(0,r.Y)(o.wc,{footnotes:["completion"],references:"1",abreviations:["eBC","HR-","mBC"],css:p,customCss:"li span, li sup {font-weight: bold;}; li sup {font-size: 59%;}"})]})}),(0,r.Y)("section",{id:"puma-patient-lynx-patient-support",children:(0,r.FD)(o.Fe,{flavor:"lightBlue",customCss:{marginTop:"0px",marginBottom:"0px",paddingTop:"60px",paddingBottom:"60px","@media (min-width: 768px)":{paddingTop:"64px",paddingBottom:"64px"}},children:[(0,r.Y)("div",{children:(0,r.FD)(o.H2,{cyan:!0,css:g,children:["Download tools to facilitate your discussions with patients receiving ",(0,r.Y)(o.z_,{})]})}),(0,r.Y)("div",{css:C,children:(0,r.Y)(o.Ft,{data:e.E.pumaSection})})]})}),(0,r.Y)("section",{id:"resources-for-your-patients",children:(0,r.FD)(o.Fe,{flavor:"dark",customCss:{marginTop:"0px",marginBottom:"0px","--tw-border-opacity":"1",borderColor:"rgba(var(--brand-yellow), var(--tw-border-opacity, 1))",paddingTop:"60px",paddingBottom:"60px",borderWidth:"0 0 8px 0","@media (min-width: 768px)":{paddingTop:"64px",paddingBottom:"64px"}},children:[(0,r.Y)("div",{children:(0,r.Y)(o.H2,{css:I,cyan:!0,children:"Resources for your patients"})}

1),(0,r.Y)(o.rK,{css:m,barColor:"cyan",bgColor:"pastelDarkBlue",description:(0,r.FD)("p",{css:d,children:["Share important resources, such as the"," ",(0,r.Y)("strong",{children:"Mentor Program"}),", with your patients to provide them support throughout their treatment."]}),children:(0,r.Y)(o.n9,{customCss:{"@media (min-width: 640px)":{paddingLeft:"4rem",paddingRight:"4rem"}},size:"cta",to:"https://nerlynx.com/her2-patient-support/#advocate-resources",children:"See what's available"})})]})}),(0,r.Y)("section",{id:"resources-copay-assistance",children:(0,r.Y)(o.s0,{})}),(0,r.Y)("section",{children:(0,r.FD)(o.Fe,{className:"resource-section",customCss:{marginTop:"0px",marginBottom:"0px",paddingTop:"60px",paddingBottom:"60px","@media (min-width: 768px)":{paddingTop:"64px",paddingBottom:"64px"}},children:[(0,r.Y)("div",{children:(0,r.FD)(o.H2,{cyan:!0,css:E,children:["Puma Patient Lynx",(0,r.Y)("sup",{children:"™"})," offers a variety of support and financial assistance programs for your patients"]})}),(0,r.FD)(o.i,{customCss:[{marginBottom:"48px",display:"grid",gridTemplateColumns:"repeat(1, minmax(0, 1fr))",gap:"50px","@media (min-width: 768px)":{gridTemplateColumns:"repeat(2, minmax(0, 1fr))"}}],className:"resource-grid",children:[(0,r.Y)(o.rK,{blue:!0,bgColor:"pastelBlue",barColor:"cyan",ctaText:"Enrollment Forms",customCss:{paddingTop:"1rem",paddingBottom:"1rem",textAlign:"center","--tw-text-opacity":"1",color:"rgba(var(--brand-gray), var(--tw-text-opacity, 1))","@media (min-width: 768px)":{paddingTop:"2rem",paddingBottom:"2rem"}},description:"Enrollment to the Puma Patient Lynx Support Program. Both forms required for access to program.",children:(0,r.FD)(o.i,{customCss:{display:"flex",flexDirection:"column","@media (min-width: 1024px)":{flexDirection:"row",flexWrap:"wrap",justifyContent:"center"}},children:[(0,r.Y)(o.fd,{customCss:{marginBottom:"1rem",display:"flex",justifyContent:"space-between",gap:"1rem","@media (min-width: 1024px)":{marginBottom:"1.5rem",marginRight:"1rem"}},to:"/pdf/PRC-US-NER-3305_HCP_EnrollmentForm.pdf",filename:"PRC-US-NER-3305_HCP_EnrollmentForm",children:"HCP: English"}),(0,r.Y)(o.fd,{customCss:{marginBottom:"1rem",display:"flex",justifyContent:"space-between",gap:"1rem","@media (min-width: 1024px)":{marginBottom:"1.5rem"}},to:"/pdf/PRC-US-NER-3365_HCP_EnrollmentForm_Spanish.pdf",filename:"PRC-US-NER-3365_HCP_EnrollmentForm_Spanish",children:"HCP: Español"}),(0,r.Y)(o.fd,{customCss:{marginBottom:"1rem",display:"flex",justifyContent:"space-between",gap:"1rem","@media (min-width: 1024px)":{marginBottom:"0px",marginRight:"1rem"}},to:"/pdf/PRC-US-NER-3338_Patient_EnrollmentForm.pdf",filename:"PRC-US-NER-3338_Patient_EnrollmentForm",children:"Patient: English"}),(0,r.Y)(o.fd,{customCss:{display:"flex",justifyContent:"space-between",gap:"1rem"},to:"/pdf/PRC-US—0033_Patient_EnrollmentForm_Spanish.pdf",filename:"PRC-US—0033_Patient_EnrollmentForm_Spanish",children:"Paciente: Español"})]})}),(0,r.Y)(o.rK,{blue:!0,bgColor:"pastelBlue",barColor:"cyan",customCss:{paddingTop:"1rem",paddingBottom:"1rem",textAlign:"center","--tw-text-opacity":"1",color:"rgba(var(--brand-gray), var(--tw-text-opacity, 1))","@media (min-width: 768px)":{paddingTop:"2rem",paddingBottom:"2rem"}},ctaText:"Co-pay Card Program*",description:"Eligible commercially insured patients treated with NERLYNX can be enrolled for co-pay assistance.",children:(0,r.Y)(o.n9,{customCss:{"@media (min-width: 640px)":{paddingLeft:"4rem",paddingRight:"4rem"}},size:"cta",to:"https://copayportal.paysign.com/enrollment/4259419922/index.html",children:"Go to patient enrollment page"})})]}),(0,r.Y)(o.wc,{footnotes:["limitations"],css:S}),(0,r.Y)(o.N3,{references:["moy b"]})]})})]})}},7604:function(A,i){i.A="data:image/jpeg;base64,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"}}]);
2//# sourceMappingURL=component---src-pages-resources-tsx-6ea7ab4c856e02177680.js.map